Polaris Quantum Biotech is a revolutionary startup that uses Quantum Computing, AI/ML, and Computational Chemistry to design novel drug leads for multiple diseases. We are seeking to hire an ambitious, highly driven, and goal-oriented DevOps Engineer with enthusiasm for infrastructure automation and end user support. We are a young startup located in the Research Triangle area, by joining us at this early stage you will have a chance to make a major contribution to the development of the company into a major player in the pharmaceutical market. The ideal candidate for this position will combine industry experience with a passion for cross-functional teams, working with key internal partners, and driving positive outcomes in a dynamic environment. This position is within a diverse, growing organization reporting to the CTO & Head of DevOps.
Polaris Quantum Biotech is a revolutionary startup that uses Quantum Computing, AI/ML, and Computational Chemistry to design novel drug leads for multiple diseases. We are seeking to hire an ambitious, highly driven, and goal-oriented Project Manager with enthusiasm for revolutionizing drug discovery. We are a young startup located in the Research Triangle area, by joining…Read More
Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech
February 3, 2022, Allosteric Bioscience, Inc., a company founded in 2021 to integrate Quantum Computing and Artificial Intelligence with various Biomedical sciences to create improved treatments for Aging, Longevity and Aging related diseases and Polaris Quantum Biotech, a company at the vanguard of Quantum Computing for drug discovery, have signed a collaboration agreement. Together, the…Read More
POLARISqb and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, today announced a collaboration to study oncology targets currently considered undruggable. Under the terms of the agreement, the POLARISqb Tachyon™ quantum computing platform will be used to scan billions of molecules from a large chemical…Read More